Medicare billing address
CMS Medicare provider billing file
4350 Malsbary RdCincinnati, OH 45242
CMS public data · NPI 1093709297
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Patrick J Ward, MD
Specialty
Credential
MD
NPI
1093709297
Primary source state
OH
Data retrieval date
July 28, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Patrick J Ward, MD from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
4350 Malsbary RdCMS Doctors & Clinicians file
4350 Malsbary RdIn the 2024 CMS provider billing file, this NPI had 371 Medicare beneficiaries and 120,828 total services. The average beneficiary age was 74, and the average HCC risk score was 2.1.
Total Medicare allowed amount
$2,837,710.39
Total Medicare payment amount
$2,257,357.29
Medicare beneficiaries
371
Total services
120,828
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hypertension
75%
CMS beneficiary-panel share
Hyperlipidemia
72%
CMS beneficiary-panel share
Ischemic heart disease
37%
CMS beneficiary-panel share
Mood disorders
32%
CMS beneficiary-panel share
Diabetes
30%
CMS beneficiary-panel share
Chronic kidney disease
29%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Injection, pembrolizumab, 1 mg | 11,400 | $55.41 |
| Injection, paclitaxel, 1 mg | 11,025 | $0.10 |
| Injection, fosaprepitant, 1 mg | 9,750 | $0.14 |
| Injection, dexamethasone sodium phosphate, 1 mg | 2,416 | $0.11 |
| Injection, palonosetron hcl, 25 mcg | 1,541 | $0.86 |
| Injection, ferric derisomaltose, 10 mg | 1,200 | $20.04 |
| Injection, granisetron hydrochloride, 100 mcg | 930 | $0.31 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 508 | $7.60 |
| Blood test, comprehensive group of blood chemicals | 449 | $10.33 |
| Administration of chemotherapy into vein, 1 hour or less | 377 | $115.62 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1093709297. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Letrozole | Letrozole | 298 | 611.4 | $4,363.82 |
| 2 | Verzenio | Abemaciclib | 60 | 60 | $906,016.76 |
| 3 | Dexamethasone | Dexamethasone | 59 | 63 | $657.81 |
| 4 | Imbruvica | Ibrutinib | 54 | 54 | $848,029.97 |
| 5 | Anastrozole | Anastrozole | 47 | 83 | $399.48 |
| 6 | Hydroxyurea | Hydroxyurea | 47 | 67.8 | $225.45 |
| 7 | Olanzapine | Olanzapine | 42 | 44.9 | $290.81 |
| 8 | Potassium Chloride | Potassium Chloride | 42 | 45 | $990.69 |
| 9 | Eliquis | Apixaban | 40 | 40 | $23,305.96 |
| 10 | Tagrisso | Osimertinib Mesylate | 40 | 40 | $653,684.60 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
Ohio State University College Of Medicine
Graduation year
1997
Group/practice field
Oncology Hematology Care Inc
Telehealth reported
Not reported
Secondary specialty fields reported by CMS: Hematology, Internal Medicine.
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.